Venous thromboembolism prophylaxis in operative traumatic brain injury
These findings suggest that initiating VTE pharmacological prophylaxis between 3 and 5 days postsurgery may be safe in operative TBI patients, with the timing dependent on the procedure's invasiveness. The low frequencies of worsening intracranial pathology and VTE support the safety of these proposed timeframes. However, the study's limitations, including its single-center retrospective nature and lack of a standardized protocol, necessitate further research to confirm these findings and establish evidence-based guidelines for VTE pharmacological prophylaxis in operative TBI patients.
Authors
- Eric Legome (ORCID: https://orcid.org/0000-0003-3567-8308)
- Konstantinos D. Margetis (ORCID: https://orcid.org/0000-0002-3715-8093)
- Jacques Lara‐Reyna (ORCID: https://orcid.org/0000-0003-2762-6460)
- Mert Karabacak (ORCID: https://orcid.org/0000-0002-9263-9893)
- Pemla Jagtiani (ORCID: https://orcid.org/0000-0002-6075-0255)
- Gijong Paik
Institutions
- Mount Sinai Health System (US)
- University of Illinois Urbana-Champaign (US)
- Illinois College (US)
- SUNY Downstate Health Sciences University (US)
- Neurological Surgery (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Surgical Neurology International
- Published
- 2024-09-20
- DOI
- https://doi.org/10.25259/sni_541_2024
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00